HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS - EVALUATION OF RESISTANCE ENGENDERED BY AMINO-ACID SUBSTITUTIONS IN THE ENZYMES SUBSTRATE-BINDING SITE

被引:45
作者
SARDANA, VV
SCHLABACH, AJ
GRAHAM, P
BUSH, BL
CONDRA, JH
CULBERSON, JC
GOTLIB, L
GRAHAM, DJ
KOHL, NE
LAFEMINA, RL
SCHNEIDER, CL
WOLANSKI, BS
WOLFGANG, JA
EMINI, EA
机构
[1] MERCK SHARP & DOHME LTD,RES LABS,DEPT MOLEC SYST,W POINT,PA 19486
[2] MERCK SHARP & DOHME LTD,RES LABS,DEPT CANC RES,W POINT,PA 19486
关键词
D O I
10.1021/bi00174a005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human immunodeficiency virus type I (HIV-1) protease is a homodimeric aspartyl endopeptidase that is required for virus replication. A number of specific, active-site inhibitors for this enzyme have been described. Many of the inhibitors exhibit significant differences in activity against the HIV-1 and HIV type 2 (HIV-2) enzymes. An initial study was conducted to ascertain the HIV-1 protease's potential to lose sensitivity to several test inhibitors while retaining full enzymatic activity. The substrate binding sites of the HIV-1 and HIV-2 enzymes are almost fully conserved, except for four amino acid residues at positions 32, 47, 76, and 82. Accordingly, recombinant mutant type 1 proteases were constructed that contained the cognate type 2 residue at each of these four positions. The substitution at position 32 resulted in a significant adverse effect on inhibitor potency. However, this substitution also mediated a noted increase in the K-m of the substrate. Individual substitutions at the remaining three positions, as well as a combination of all four substitutions, had very little effect on enzyme activity or inhibitor susceptibility Hence, the four studied active site residues are insufficient to be responsible for differences in inhibitorsensitivity between the HIV-1 and HIV-2 proteases and are unlikely to contribute to the generation of inhibitor-resistant mutant HIV-1 protease.
引用
收藏
页码:2004 / 2010
页数:7
相关论文
共 37 条
  • [1] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [2] X-RAY CRYSTAL-STRUCTURE OF THE HIV PROTEASE COMPLEX WITH L-700,417, AN INHIBITOR WITH PSEUDO C2 SYMMETRY
    BONE, R
    VACCA, JP
    ANDERSON, PS
    HOLLOWAY, MK
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (24) : 9382 - 9384
  • [3] STABILITY AND ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE - COMPARISON OF THE NATURAL DIMER WITH A HOMOLOGOUS, SINGLE-CHAIN TETHERED DIMER
    CHENG, YSE
    YIN, FH
    FOUNDLING, S
    BLOMSTROM, D
    KETTNER, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) : 9660 - 9664
  • [4] ANTIVIRAL PROPERTIES OF RO 31-8959, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PROTEINASE
    CRAIG, JC
    DUNCAN, IB
    HOCKLEY, D
    GRIEF, C
    ROBERTS, NA
    MILLS, JS
    [J]. ANTIVIRAL RESEARCH, 1991, 16 (04) : 295 - 305
  • [5] DARKE PL, 1989, J BIOL CHEM, V264, P2307
  • [6] HUMAN IMMUNODEFICIENCY VIRUS PROTEASE EXPRESSED IN ESCHERICHIA-COLI EXHIBITS AUTOPROCESSING AND SPECIFIC MATURATION OF THE GAG PRECURSOR
    DEBOUCK, C
    GORNIAK, JG
    STRICKLER, JE
    MEEK, TD
    METCALF, BW
    ROSENBERG, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 8903 - 8906
  • [7] SIMULTANEOUS ANALYSIS OF FAMILIES OF SIGMOIDAL CURVES - APPLICATION TO BIOASSAY, RADIOLIGAND ASSAY, AND PHYSIOLOGICAL DOSE-RESPONSE CURVES
    DELEAN, A
    MUNSON, PJ
    RODBARD, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 235 (02): : E97 - E102
  • [8] DIXON M, 1979, ENZYMES, P361
  • [9] DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE
    ERICKSON, J
    NEIDHART, DJ
    VANDRIE, J
    KEMPF, DJ
    WANG, XC
    NORBECK, DW
    PLATTNER, JJ
    RITTENHOUSE, JW
    TURON, M
    WIDEBURG, N
    KOHLBRENNER, WE
    SIMMER, R
    HELFRICH, R
    PAUL, DA
    KNIGGE, M
    [J]. SCIENCE, 1990, 249 (4968) : 527 - 533
  • [10] FITZGERALD PMD, 1990, J BIOL CHEM, V265, P14209